ABSTRACT The lung function of 21 patients with leukaemia (11 with acute myeloid leukaemia, six with acute lymphatic leukaemia, four with chronic myeloid leukaemia) and of five with severe aplastic anaemia was tested before and after allogenic bone marrow transplantation. Vital capacity (VC) was lowered in patients with leukaemia before transplantation. VC and FEV, fell significantly after transplantation. Residual volume (RV) and RV as a percentage of total lung capacity (RV % TLC) were already increased and rose significantly after transplantation. Patients with severe aplastic anaemia had noticeably increased RV and RV % TLC, values that did not change after transplantation. In contrast to the patients with aplastic anaemia, the patients with leukaemia had significantly reduced VC, RV, RV % TLC, and FEV1 before and after transplantation. The specific airway resistance (sRaw) was raised significantly before and after transplantation in the leukaemic patients. In addition, transfer coefficient (Kco) fell significantly more after transplantation in the patients with leukaemia than in those with severe aplastic anaemia. In three patients with histologically established obstructive bronchiolitis in conjunction with chronic graft versus host disease after transplantation, VC, FEV, and FEV, % VC fell, while RV, RV % TLC, and sRaw rose; Kco was far below normal. On the basis of these findings it is concluded that in patients with leukaemia obstructive disorders of ventilation develop or, if they are already present, worsen. In patients with severe aplastic anaemia lung function was not impaired in the early phase after transplantation. These differences are probably due to the more intensive immunosuppressive and cytotoxic preparatory regimen before transplantation in the leukaemic patients. Obstructive bronchiolitis, a complication of graft versus host disease, first manifests itself in a typical rise in specific airway resistance and must be treated early. 
Bone marrow transplantation for the treatment of haematological disorders leads to lung diseases in over half of all patients.`1 Such pulmonary diseases are the most common lethal complications of this form of treatment. 23 In addition to pneumonia, restrictive and obstructive lung function changes have been described after transplantation.56 An obstructive bronchiolitis of uncertain pathological origin but correlated with chronic graft versus host disease has been reported by several transplantation centres.71 -o Finally, a reduction in transfer factor (diffusing capacity) after transplantation has also been For these reasons we examined the lung functions of 26 patients before and after bone marrow transplantation and compared the results obtained in patients with leukaemia with those from patients with severe aplastic anaemia. Special attention was paid to cases where obstructive bronchiolitis was also present.
Methods

PATIENTS
Twenty six patients (10 female) aged from 6 to 29 (median 19) years were examined. The diagnoses were: acute leukaemia in remission (16 patients) or in relapse (one patient), chronic myeloid leukaemia (four patients), and severe aplastic anaemia (five patients). Details are given in table 1 . All received bone marrow from siblings who were completely matched in the HLA-A, B, C, DR system and whose
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Lung function changes after allogenic bone marrow transplantation tp < 0.001 for difference before transplantation between patients with leukaemia and with aplastic anaemia. $p < 0.01 for difference before transplantation between patients with leukaemia and with aplastic anaemia. VC-vital capacity; TGV-thoracic gas volume; RV-residual volume; RV % TLC-RV as % of total lung capacity; TLC-total lung capacity; Raw-airways resistance; sRaw-specific airways resistance; Kco-transfer coefficient. VC   65   50   103  49  67  59  78  53  TGV  130  142  148  198  90  121  123  154  RV  206  263  130  316  160  227  165  269  RV % TLC  203  253  110  277  184  240  166  257  TLC  99  103  106  103  87  95  97  100   FEV1   61  44  133  40  79  55  91  46  FEV1% VC   94  89  130  81  117  92  114  87  Raw  123  228  107  362  139  167  123  252  sRaw  160  323  159  715  126  201  148  413  Kco   -58   -65 59 60
Abbreviations as in tables I and 2.
Lung function changes after allogeneic bone marrow transplantation graft versus host disease are shown in The following pre-transplantation measurements (table 2) were significantly lower in patients with leukaemia than in those with severe aplastic anaemia: VC, RV (p < 0.001), RV % TLC (p < 0.01), FEV, (p < 0.01), and Kco (p < 0.001). sRaw was significantly higher (p < 0.01). Thus before transplantation patients with leukaemia had less severe pulmonary hyperinflation but more severe airway obstruction than those with severe aplastic anaemia. There was no difference in TLCO between the two groups before transplantation. After transplantation pulmonary hyperinflation and obstruction increased further in the leukaemic patients, which made the differences between the two groups even greater.
Comparison between the two groups of the posttransplantation values of VC, RV, RV % TLC, and sRaw showed highly significant differences (p < 0.001).
Discussion
The present study shows a striking difference between patients with leukaemia and those with severe aplastic anaemia. Even before bone marrow transplantation the leukaemic patients had more pulmonary hyperinflation with greater than normal residual volume and lower than normal vital capacity. Specific airway resistance was likewise increased. These findings indicate the presence of bronchial obstruction, the cause of which has not been established. One conceivable cause could be the cytostatic chemotherapy17 to which all of the patients with leukaemia were subjected in the course of primary treatment. Usually, however, chemotherapy has been cited as the cause of interstitial pulmonary changes with subsequent fibrosis and restrictive losses in function.'8 In contrast to the patients with severe aplastic anaemia, the leukaemic patients showed significant lowering of VC, RV, RV % TLC, and Kco before transplantation, while sRaw was significantly raised. In contrast to the leukaemic patients, the patients with aplastic anaemia appeared to have appreciable pulmonary hyperinflation but no substantial obstruction. After transplantation the leukaemic patients' VC and FEV1 decreased while RV and RV % TLC increased significantly. The changes in lung volumes are the result of a further increase in bronchial obstruction. Similar findings after transplantation have been reported by others.56 The comparison with the patients with aplastic anaemia shows the differences that already existed before transplantation, as well as significantly raised sRaw and significantly lowered Kco in patients with leukaemia. One important factor leading to this difference is likely to be the total body irradiation given to the leukaemic patients before transplantation, since the other measures connected with transplantation were similar for the two groups of patients. Possibly total body irradiation causes damage to the alveolarendothelial membrane, which could contribute to reduction in transfer factor-as has been postulated by other authors who have found lowered TLCO after transplantation." 12
So far, we have been able to test lung function in three patients with obstructive bronchiolitis after transplantation. All three patients showed changes indicating an obliterative process in the small airways. Similar changes have been found by others.9 10 19 20-23 All of the patients observed in Tubingen with obstructive bronchiolitis (five patients-two of them are not mentioned in this study) also had acute or chronic graft versus host disease, an association confirmed by others.7 -10 19 -23 In a large scale series in Seattle no association between graft versus host disease and obstructive lung disease was found, but the patients with features of obstructive defects of lung function examined more than four years after bone marrow transplantation usually also had chronic graft versus host disease.5 21 Probably we need to distinguish between the moderate obstruction after transplantation that usually occurs in leukaemic patients and obstructive bronchiolitis, which can be histologically established and which according to all the data so far published occurs only in conjunction with graft versus host disease. The pathogenesis of these latter bronchial and bronchiolar obstructions is still unclear. A connection with chronic graft versus host disease is likely since this late complication triggers a fibrotic process in several organs and shows some similarities to autoimmune diseases,24 such as systemic sclerosis, sys-temic lupus erythematosus, and Sj6gren's disease. Obstructive bronchiolitis can also occur as a complication of these autoimmune diseases. 1 7 On the basis of these results we conclude that patients with leukaemia receiving total body irradiation develop obstructive ventilatory disorders. The lung function of patients with severe aplastic anaemia, by contrast, is only slightly impaired in the first six months after transplantation. Particular attention must be paid to the development of bronchiolar obstruction in patients with graft versus host disease, since obstructive bronchiolitis may be a manifestation of graft versus host disease. In view of the poor prognosis of this complication, immediate treatment with immunosuppressants is indicated in such cases. 7 9 16 18 
